Dokter Maxime Borreman
ActiveDokter Maxime Borreman has been active since 2014 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €986k and a net result of €182k. Equity is growing by ~17.8% per year across the filed fiscal years. Its solvency ranks better than 91% of 2293 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
100
/ 100
Excellent= vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability92▲+14
Solvency100=
Growth78=
Stability100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €100k at 30 days acceptable
Liquidity ample (current ratio 46.59 against 23.86 in 2024), and 5.4% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
94.6%
Return on assets
17.4%
Age of the figures
8 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-08-2026, 23 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
23 d late
2024
6 d late
2023
54 d early
2022
14 d early
2021
30 d late
2020
26 d late
2019
84 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
15-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€986k▲ 12.7%
2024 · €875k
2018: €205k
2019: €381k
2020: €498k
2021: €562k
2022: €628k
2023: €738k
2024: €875k
2018 → 2025
Total assets
€1.04M▲ 8.1%
2024 · €964k
2018: €430k
2019: €591k
2020: €688k
2021: €709k
2022: €714k
2023: €876k
2024: €964k
2018 → 2025
Net result
€182k▲ 33.1%
2024 · €137k
2018: €99k
2019: €176k
2020: €117k
2021: €134k
2022: €106k
2023: €110k
2024: €137k
2018 → 2025
Working capital
€843k▲ 14.8%
2024 · €734k
2018: €142k
2019: €316k
2020: €397k
2021: €415k
2022: €475k
2023: €583k
2024: €734k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€562k-€628k▲ 11.8%€738k▲ 17.6%€875k▲ 18.5%€986k▲ 12.7%
Operating result€197k-€173k▼ 12.0%€175k▲ 1.0%€202k▲ 15.8%€237k▲ 17.0%
Net result€134k-€106k▼ 20.7%€110k▲ 4.0%€137k▲ 23.6%€182k▲ 33.1%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed three years in a row; 2025 is 17% above 2024 and is the highest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.04M
Fixed assets
€181k▼ 8.8%
Current assets
€861k▲ 12.4%
Equity and liabilities €1.04M
Equity
€986k▲ 12.7%
Debt
€56k▼ 37.5%
The debt ratio falls from 9.3% to 5.4%: equity grows while debt is paid down.
Key figures and ratios
EBITDA
€295k▲
2024 · €257k
Cash flow
€240k▲
2024 · €191k
Solvency
94.6%▲
2024 · 90.7%
Current ratio
46.59▲
2024 · 23.86
Quick ratio
46.59▲
2024 · 23.86
Debt / equity
0.06▼
2024 · 0.10
ROE
18.4%▲
2024 · 15.6%
ROA
17.4%▲
2024 · 14.2%
Interest coverage
95.57▲
2024 · 43.14
Debt
€56k▼
2024 · €90k
Debt ≤ 1 year
€18k▼
2024 · €32k
Debt > 1 year
€37k▼
2024 · €57k
Income taxes
€56k▼
2024 · €60k
Staff costs
€998▲
2024 · €495
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€964k€1.04M▲
Fixed assets21/28€198k€181k▼
Tangible fixed assets22/27€198k€181k▼
Plant, machinery and equipment23€7k€14k▲
Furniture and vehicles24€68k€44k▼
Other tangible fixed assets26€124k€123k▼
Current assets29/58€766k€861k▲
Amounts receivable within one year40/41€42k€199k▲
Other amounts receivable41€42k€199k▲
Current investments50/53€80k€200k▲
Cash at bank and in hand54/58€640k€457k▼
Deferred charges and accrued income490/1€4k€5k▲
Equity and liabilities
Total equity and liabilities10/49€964k€1.04M▲
Equity10/15€875k€986k▲
Contributions10/11€19k-
Capital10€19k-
Issued capital100€19k-
Reserves13€856k€986k▲
Non-distributable reserves130/1€2k-
Legal reserve130€2k-
Tax-exempt reserves132€25k€25k=
Distributable reserves133€830k€961k▲
Amounts payable17/49€90k€56k▼
Amounts payable after more than one year17€57k€37k▼
Financial debts170/4€57k€37k▼
Amounts payable within one year42/48€32k€18k▼
Current portion of amounts payable after more than one year42€32k€18k▼
Income statement
Code20242025
Remuneration, social security and pensions62€495€998▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€54k€58k▲
Other operating charges640/8€733€781▲
Gross operating margin9900€258k€297k▲
Operating profit (loss)9901€202k€237k▲
Financial income75/76B-€4k
Recurring financial income75-€2k
Non-recurring financial income76B-€3k
Financial charges65/66B€6k€3k▼
Recurring financial charges65€6k€3k▼
Profit (loss) for the period before taxes9903€197k€238k▲
Income taxes67/77€60k€56k▼
Profit (loss) for the period9904€137k€182k▲
Profit (loss) for the period to be appropriated9905€137k€182k▲
Appropriation of the result
Profit (loss) to be appropriated9906€137k€182k▲
Transfer from equity791/2-€52k
Transfer to equity691/2€137k€182k▲
To other reserves6921€137k€182k▲
Profit to be distributed694/7-€52k
Return on contributions (dividend)694-€52k
The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
23-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 23 days late
2025
31-12
Financial
Highest result since 2018net €182k ▲33.1%
Operating result €237k, net result €182k, both a record.
06-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 6 days late
2024
07-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
17-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
30-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 30 days late
2021
31-12
Financial
Equity above €500kEq €562k ▲12.8%
4 profitable years in a row build equity to €562k.
26-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 26 days late
2020
31-12
Financial
Liquidity triplescurrent ratio 8.42
Current ratio from 3.02 to 8.42; short-term debt falls from €157k to €54k.
23-10
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 84 days late
2019
22-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 22 days late
2018
26-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
25-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 25 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sint-Truiden · 1 establishment unit since 2014
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Hasseltsesteenweg 3073800 Sint-TruidenGround area
1,728 m²
Building footprint
218 m²
Volume, LiDAR
1,501 m³
2 parcels, Flanders · tallest building 15.5 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Dokter Maxime Borreman
since 20142.226.892.742
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71352B0600/00C000 | Flanders | 991 m² | 1 · 69 m² | 15.5 m · 3 fl. |
| 71352A0200/00G000 | Flanders | 736 m² | 1 · 149 m² | 7.2 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr. Adriaenssens & Stallaert
BE 0865.475.471
Antwerpen · Eq €987k
DOKTER HASSAN KAYS
BE 0830.994.050
Antwerpen · Eq €985k
DOKTER VANDEWAL
BE 0870.942.313
Brugge · Eq €984k
CABINET MEDICAL DES DOCTEURS COMELIAU ET DETRY
BE 0845.570.477
Jalhay · Eq €984k
DR. CALLEBAUT - DR. ORLANS
BE 0899.830.792
Jabbeke · Eq €984k
Of 9,101 companies in sector 86210 we hold annual accounts for 6,323. 4,067 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded07-02-2014
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 12 filingsAddress and cadastre registers
Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.